American Vietnamese Biotech Incorporation announced earnings results for the fourth quarter ended December 31, 2018. For the fourth quarter, the company announced total revenue was VND 297,000.000 million compared to VND 61,385.659 million a year ago. Operating income was VND 123,000.000 million compared to VND 38,178.251 million a year ago. Net income was VND 120,000.000 million compared to VND 37,456.843 million a year ago. Basic earnings per share was VND 4,425 compared to VND 1,381 a year ago. For the full year, total revenue was VND 461,000.000 million compared to VND 71,868.340 million a year ago. Operating income was VND 220,000.000 million compared to VND 39,366.577 million a year ago. Net income was VND 215,000.000 million compared to VND 38,465.951 million a year ago. Basic earnings per share was VND 7,917 compared to VND 3,521 a year ago.